Beau Visser
Associate | Attorney at law
T. +41 58 510 92 30
beau.visser@advestra.ch
Beau Visser focuses her practice on capital markets transactions (equity and debt), in particular covering IPOs and public takeovers. She regularly advises public companies and their shareholders on their reporting and disclosure obligations.
Her practice covers corporate matters, in particular corporate governance and equity plans, as well as commercial agreements.
- Associate at Advestra (since 2024)
- Admitted to the Bar of the canton of Zurich (2024)
- Secondment at a Swiss listed company active in the fields of generic pharmaceuticals and biosimilars (2023)
- Associate at Baker McKenzie Switzerland (2020 – 2024)
- Associate at Baker McKenzie Amsterdam (2016 – 2019)
- Admitted to the Dutch Bar (2016)
- Traineeship at Baker McKenzie Amsterdam (2015)
- Traineeship at ScheerSanders Attorneys The Hague (2015)
- MLaw at University of Amsterdam (2015)
- BLaw at University of Amsterdam (2014)
- Zurich Bar Association (ZAV)
- Netherlands Bar Association (NOvA)
- Dutch
- English
- German
- Swiss Courts
- Dutch Courts
- Advestra advises the shareholders of Viterra Limited in the merger with Bunge Global
- Advestra advises UBS comprehensively on the debt and equity financing of Rieter’s acquisition of OC Oerlikon’s Barmag textile machinery business for manmade fibers
- Advestra advises Barry Callebaut on the placement of EUR-Bonds in the amount of EUR 1.75 billion
- Advestra advises the founders of Supercar Owners Circle on its acquisition by duPont REGISTRY Group LLC
- Advestra advises Barry Callebaut on the placement of CHF 300 million bonds
- Advestra advises MIGx Management and Shareholders on a Partnership with GREENPEAK Partners
- Advestra advises LOGEX on the acquisition of INMED
- Advestra advises eMolecules Inc. and Avista Healthcare Partners on the acquisition of Synple Chem AG